BTG to Buy Assets from Banco Master, Shareholders
Banco BTG Pactual SA has reached an agreement to acquire about 1.5 billion reais ($266 million) in assets from troubled Banco Master SA and its shareholders, according to people with knowledge of the matter.
The assets include the five-star Fasano hotel located in Itaim, one of São Paulo's most upscale neighborhoods, according to the people, who asked not to be identified discussing private information.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
TD Cowen Maintains Buy Rating on Franklin Resources (BEN), Keeps $27 PT
On June 5, William Katz from TD Cowen maintained a Buy rating on Franklin Resources, Inc. (NYSE:BEN) and kept the price target unchanged at $27. The reiterated Buy rating comes after the company released its preliminary month-end Assets Under Management report. Franklin Resources, Inc. (NYSE:BEN) reported that its preliminary month-end assets under management (AUM) totaled $1.57 trillion, as of May 31. The AUM increased month-over-month from $1.53 trillion as of April 30. Management noted this increase as a reflection of positive market conditions. The company reported net inflows of $1 billion, including the $3 billion outflows at Western Asset Management, a subsidiary. A close-up of an investor making a transaction, with a financial graph reflecting the market trend. Katz noted Franklin Resources, Inc. (NYSE:BEN) exceeded long-term inflows expectations. Katz remains optimistic regarding the company's future performance expecting stronger core flows and a reduction in WAMCO-related run-off. Franklin Resources, Inc. (NYSE:BEN) is a global investment management company serving over 150 countries. The company specializes in equity, fixed-income, and multi-asset solutions for retail, institutional, and high-net-worth investors through its various brands. While we acknowledge the potential of BEN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Cellebrite DI Ltd. (CLBT) to Acquire Corellium
Cellebrite DI Ltd. (NASDAQ:CLBT) makes a move to acquire Corellium, a developer of Arm-based virtualization software. The transaction is valued at $170 million in cash, plus up to $30 million in contingent consideration, and reflects the company's deepening footprint across the mobile security and digital intelligence spectrum. A female engineer in a datacenter, wearing a headset, monitoring digital data. The acquisition of Corellium introduces mobile vulnerability research tools, smart device DevSecOps, and virtual device testing, thereby complementing Cellebrite DI Ltd. (NASDAQ:CLBT)'s plan to expand beyond traditional digital investigations. The company's Interim CEO, Thomas E. Hogan, has further made the following statement. 'The combination of our respective talent and IP changes the game in the efficient securing and analysis of all Arm-based devices.' Cellebrite DI Ltd. (NASDAQ:CLBT)'s shares opened at $16.85 today. The acquisition is pending regulatory approval and is expected to close this summer. This timing stands close to the company's plans to announce the appointment of the permanent CEO. Though the stock's monthly performance has declined by 11.94%, its weekly performance has seen an uptick of 2.18%, potentially influenced by the acquisition buzz. The Israeli company, Cellebrite DI Ltd. (NASDAQ:CLBT), established under the telecommunications and digital intelligence industries, offers advanced digital forensics tools to law enforcement, intelligence agencies, and enterprises worldwide. With a market capitalization of $4.06 billion, the company is best known for its flagship product series, Cellebrite UFED. While we acknowledge the potential of CLBT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 10 Unstoppable Dividend Stocks to Buy Now and 11 Oversold Global Stocks to Buy According to Hedge Funds Disclosure: None. Sign in to access your portfolio
Bloomberg
an hour ago
- Bloomberg
Goldman Sachs Leads Simetrik Series B Extension to $85 Million
Simetrik, a financial and accounting services startup, raised $30 million in fresh funding led by a unit of Goldman Sachs Alternatives. The funding adds to a series B round that the company disclosed in February 2024. At that point it had already pulled in $55 million from investors led by the growth equity team at Goldman Sachs Asset Management's alternatives platform.
